Calliditas Therapeutics Ab (publ)
(NASDAQ) CALT
This security has been delisted. This page is retained for historical reference.
CALT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowCALT Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-32%
Net Income Margin
-39%
Return on Equity
-85%
Return on Capital
-26%
Return on Assets
-25%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
SEK 1.13B
Operating Income
-SEK 384.40M
EBITDA
-SEK 367.80M
Operating Cash Flow
-SEK 434.66M
Capital Expenditure
-SEK 12.79M
Free Cash Flow
-SEK 447.44M
Cash & ST Invst.
SEK 973.73M
Total Debt
SEK 979.13M
Calliditas Therapeutics Ab (publ) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
SEK 559.78M
+107.8%
Gross Profit
SEK 506.33M
+98.4%
Gross Margin
90.45%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
222
N/A
Net Income
-SEK 47.48M
+48.4%
EBITDA
-SEK 28.81M
+61.4%
Quarterly Fundamentals
Net Cash
-SEK 210.99M
-343.6%
Accounts Receivable
SEK 317.02M
+38.0%
Inventory
SEK 40.16M
+127.0%
Long Term Debt
SEK 1.01B
+29.3%
Short Term Debt
SEK 0.00
N/A
Return on Assets
-24.53%
N/A
Return on Invested Capital
-25.74%
N/A
Free Cash Flow
-SEK 7.04M
+95.7%
Operating Cash Flow
-SEK 7.04M
+95.7%